Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Xuejun Chen

14PUBLICATIONS
141CO-AUTHORS
Innate immunityComputational linguisticsMedical devicesMedical virologyNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

Sort by Publication Date:
|Aug 28, 2024
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIV<sub>AD8-EO</sub> infection.

Joana Dias, Giulia Fabozzi, Slim Fourati

|May 16, 2024
Heterologous prime-boost vaccination drives early maturation of HIV broadly neutralizing antibody precursors in humanized mice.

Christopher A Cottrell, Xiaozhen Hu, Jeong Hyun Lee

|Jan 17, 2024
Antibodies targeting the fusion peptide on the HIV envelope provide protection to rhesus macaques against mucosal SHIV challenge.

Amarendra Pegu, Sarah E Lovelace, Megan E DeMouth

|Jan 04, 2024
Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability.

Jason Gorman, Crystal Sao-Fong Cheung, Zhijian Duan

|Apr 12, 2022
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial.

Joseph P Casazza, Evan M Cale, Sandeep Narpala

|Dec 10, 2021
A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques.

Peng Zhang, Elisabeth Narayanan, Qingbo Liu

Pageof 3

Frequent Collaborators

5 joint publications

Amarendra Pegu

5 joint publications

Peter D Kwong

4 joint publications

John R Mascola

4 joint publications

Nicole Doria-Rose

3 joint publications

Mark Louder

3 joint publications

Kevin O Saunders

3 joint publications

Misook Choe

3 joint publications

Stephen D Schmidt

3 joint publications

Tongqing Zhou

3 joint publications

Adrian McDermott

Frequent Collaborators

5 joint publications

Amarendra Pegu

5 joint publications

Peter D Kwong

4 joint publications

John R Mascola

4 joint publications

Nicole Doria-Rose

Top Related Videos

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
13:47

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Published on : Jun 23, 2011

19.6K
Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model
11:38

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model

Published on : Jul 02, 2016

10.5K
Production of <em>E. coli</em>-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
00:10

Production of <em>E. coli</em>-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on : Aug 21, 2019

7.6K
See more related videos

Top Related Videos

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
13:47

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Published on : Jun 23, 2011

19.6K
Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model
11:38

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model

Published on : Jul 02, 2016

10.5K
Production of <em>E. coli</em>-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
00:10

Production of <em>E. coli</em>-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on : Aug 21, 2019

7.6K
See more related videos